Vaccinex Stock Technical Analysis
| VCNX Stock | USD 1.30 0.02 1.52% |
As of the 28th of January, Vaccinex has the Risk Adjusted Performance of 0.0948, semi deviation of 11.89, and Coefficient Of Variation of 863.59. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vaccinex, as well as the relationship between them.
Vaccinex Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vaccinex, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VaccinexVaccinex |
Vaccinex 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vaccinex's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vaccinex.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Vaccinex on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Vaccinex or generate 0.0% return on investment in Vaccinex over 90 days. Vaccinex is related to or competes with Medigene, Chia Tai, and Biomind Labs. Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through... More
Vaccinex Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vaccinex's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vaccinex upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 17.33 | |||
| Information Ratio | 0.1109 | |||
| Maximum Drawdown | 101.27 | |||
| Value At Risk | (25.37) | |||
| Potential Upside | 32.35 |
Vaccinex Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaccinex's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vaccinex's standard deviation. In reality, there are many statistical measures that can use Vaccinex historical prices to predict the future Vaccinex's volatility.| Risk Adjusted Performance | 0.0948 | |||
| Jensen Alpha | 1.85 | |||
| Total Risk Alpha | 0.3443 | |||
| Sortino Ratio | 0.1042 | |||
| Treynor Ratio | 4.38 |
Vaccinex January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0948 | |||
| Market Risk Adjusted Performance | 4.39 | |||
| Mean Deviation | 9.73 | |||
| Semi Deviation | 11.89 | |||
| Downside Deviation | 17.33 | |||
| Coefficient Of Variation | 863.59 | |||
| Standard Deviation | 16.29 | |||
| Variance | 265.36 | |||
| Information Ratio | 0.1109 | |||
| Jensen Alpha | 1.85 | |||
| Total Risk Alpha | 0.3443 | |||
| Sortino Ratio | 0.1042 | |||
| Treynor Ratio | 4.38 | |||
| Maximum Drawdown | 101.27 | |||
| Value At Risk | (25.37) | |||
| Potential Upside | 32.35 | |||
| Downside Variance | 300.48 | |||
| Semi Variance | 141.42 | |||
| Expected Short fall | (12.44) | |||
| Skewness | 0.7442 | |||
| Kurtosis | 3.86 |
Vaccinex Backtested Returns
Vaccinex is out of control given 3 months investment horizon. Vaccinex owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14 % return per unit of risk over the last 3 months. We were able to interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 2.43% are justified by taking the suggested risk. Use Vaccinex Risk Adjusted Performance of 0.0948, semi deviation of 11.89, and Coefficient Of Variation of 863.59 to evaluate company specific risk that cannot be diversified away. Vaccinex holds a performance score of 11 on a scale of zero to a hundred. The entity has a beta of 0.43, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Vaccinex's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vaccinex is expected to be smaller as well. Use Vaccinex rate of daily change, relative strength index, as well as the relationship between the semi variance and sortino ratio , to analyze future returns on Vaccinex.
Auto-correlation | 0.39 |
Below average predictability
Vaccinex has below average predictability. Overlapping area represents the amount of predictability between Vaccinex time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vaccinex price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Vaccinex price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Vaccinex technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Vaccinex Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Vaccinex across different markets.
About Vaccinex Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vaccinex on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vaccinex based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vaccinex price pattern first instead of the macroeconomic environment surrounding Vaccinex. By analyzing Vaccinex's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vaccinex's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vaccinex specific price patterns or momentum indicators. Please read more on our technical analysis page.
Vaccinex January 28, 2026 Technical Indicators
Most technical analysis of Vaccinex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vaccinex from various momentum indicators to cycle indicators. When you analyze Vaccinex charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0948 | |||
| Market Risk Adjusted Performance | 4.39 | |||
| Mean Deviation | 9.73 | |||
| Semi Deviation | 11.89 | |||
| Downside Deviation | 17.33 | |||
| Coefficient Of Variation | 863.59 | |||
| Standard Deviation | 16.29 | |||
| Variance | 265.36 | |||
| Information Ratio | 0.1109 | |||
| Jensen Alpha | 1.85 | |||
| Total Risk Alpha | 0.3443 | |||
| Sortino Ratio | 0.1042 | |||
| Treynor Ratio | 4.38 | |||
| Maximum Drawdown | 101.27 | |||
| Value At Risk | (25.37) | |||
| Potential Upside | 32.35 | |||
| Downside Variance | 300.48 | |||
| Semi Variance | 141.42 | |||
| Expected Short fall | (12.44) | |||
| Skewness | 0.7442 | |||
| Kurtosis | 3.86 |
Vaccinex January 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Vaccinex stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 18.42 | ||
| Daily Balance Of Power | (0.11) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 1.21 | ||
| Day Typical Price | 1.24 | ||
| Price Action Indicator | 0.08 | ||
| Market Facilitation Index | 0 |
Additional Tools for Vaccinex Pink Sheet Analysis
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.